Literature DB >> 15675653

Cancer pain, fatigue, distress, and insomnia in cancer patients.

Dale E Theobald1.   

Abstract

Insomnia is common among cancer patients, occurring in approximately 30% to 50% of the cancer population. The interactions between cancer pain, insomnia, fatigue, and depression/anxiety are complex, warranting treatment plans that focus not only on the relief of specific symptoms to improve quality of life but also on the impact of treatment on other related symptoms. Pain is one of the most common symptoms experienced by cancer patients and is one of the primary factors that precipitate insomnia in this population. Fatigue is also commonly reported by cancer patients, with a prevalence of nearly 80% in some tumor types. Cancer-related fatigue occurs most often after surgery, chemotherapy, radiotherapy, or immunotherapy and has been reported by cancer patients to be the major obstacle to normal functioning and a good quality of life. Insomnia in cancer patients often occurs in association with psychological disorders such as depression or anxiety. Sleep disturbances are associated with aberrant patterns of cortisol secretion, such as those found in insomnia, which are known to significantly depress the immune system, particularly the cells of the immune system responsible for mounting a defense against tumors. Evidence suggests that management of insomnia through a combination of pharmacologic and nonpharmacologic means can have a positive impact not only on insomnia but also on related symptoms and, consequently, on overall health and quality of life. Although the treatment of insomnia in cancer patients can improve cancer-related fatigue, immune functioning, and overall quality of life, insomnia in the context of cancer is still undertreated. Physicians should use hypnotic agents appropriately and be aware of the reduced potential for producing tolerance and dependence with the nonbenzodiazepine hypnotic agents. The management of insomnia in cancer patients should include a global treatment plan designed to address not only the underlying sleep disturbance but also the related symptoms that may contribute to insomnia or occur as a result of it.

Entities:  

Mesh:

Year:  2004        PMID: 15675653     DOI: 10.1016/s1098-3597(05)80003-1

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  50 in total

1.  Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life.

Authors:  Karis Kin Fong Cheng; Vincent Lee; Chak Ho Li; Hui Leung Yuen; Joel B Epstein
Journal:  Support Care Cancer       Date:  2011-12-14       Impact factor: 3.603

Review 2.  Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer.

Authors:  Kristine L Kwekkeboom; Catherine H Cherwin; Jun W Lee; Britt Wanta
Journal:  J Pain Symptom Manage       Date:  2009-11-08       Impact factor: 3.612

3.  Occurrence and predictors of the fatigue in high-grade glioma patients.

Authors:  Irene Aprile; Silvia Chiesa; Luca Padua; Chiara Di Blasi; Maria Felice Arezzo; Vincenzo Valentini; Enrico Di Stasio; Mario Balducci
Journal:  Neurol Sci       Date:  2015-02-20       Impact factor: 3.307

4.  Pilot study of cranial stimulation for symptom management in breast cancer.

Authors:  Debra E Lyon; Christine Schubert; Ann Gill Taylor
Journal:  Oncol Nurs Forum       Date:  2010-07       Impact factor: 2.172

5.  Theory-based evaluation of an online cancer fatigue class.

Authors:  Tenbroeck Smith; Kristi Richardson; Corinne Crammer; Greta Greer; Kevin D Stein; C Christina Mehta; James L Kepner
Journal:  J Cancer Educ       Date:  2010-09       Impact factor: 2.037

6.  Sleep dysfunction in patients with cancer.

Authors:  Lavinia Fiorentino; Sonia Ancoli-Israel
Journal:  Curr Treat Options Neurol       Date:  2007-09       Impact factor: 3.598

7.  Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy.

Authors:  Lianqi Liu; Lavinia Fiorentino; Loki Natarajan; Barbara A Parker; Paul J Mills; Georgia Robins Sadler; Joel E Dimsdale; Michelle Rissling; Feng He; Sonia Ancoli-Israel
Journal:  Psychooncology       Date:  2009-02       Impact factor: 3.894

8.  Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting.

Authors:  Jennifer L Steel; David A Geller; Kevin H Kim; Lisa H Butterfield; Michael Spring; Jonathan Grady; Weiing Sun; Wallis Marsh; Michael Antoni; Mary Amanda Dew; Vicki Helgeson; Richard Schulz; Allan Tsung
Journal:  Cancer       Date:  2016-03-11       Impact factor: 6.860

9.  Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.

Authors:  Linda Witek-Janusek; Kevin Albuquerque; Karen Rambo Chroniak; Christopher Chroniak; Ramon Durazo-Arvizu; Herbert L Mathews
Journal:  Brain Behav Immun       Date:  2008-03-21       Impact factor: 7.217

10.  Factor structure of the Hospital Anxiety and Depression Scale in Japanese psychiatric outpatient and student populations.

Authors:  Tomomi Matsudaira; Hiromi Igarashi; Hiroyoshi Kikuchi; Rikihachiro Kano; Hiroshi Mitoma; Kiyoshi Ohuchi; Toshinori Kitamura
Journal:  Health Qual Life Outcomes       Date:  2009-05-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.